Midlothian, United Kingdom

Juan Manuel Iglesias

This inventor holds 2 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: Askbio Inc., Asklepios Biopharmaceutical, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juan Manuel Iglesias. Retrieved from https://idiyas.com/inventor/juan-manuel-iglesias

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Juan Manuel Iglesias

Introduction

Juan Manuel Iglesias is a notable inventor based in Midlothian, GB. He has made significant contributions to the field of biotechnology, particularly in the area of regulatory nucleic acid sequences. With a total of 2 patents to his name, Iglesias has established himself as a key figure in his domain.

Latest Patents

His latest patents include "Regulatory Nucleic Acid Sequences" and "Liver-Specific Regulatory Nucleic Acid Sequences." These innovations reflect his commitment to advancing scientific knowledge and improving therapeutic approaches.

Career Highlights

Throughout his career, Iglesias has worked with prominent companies such as AskBio Inc. and Asklepios Biopharmaceutical, Inc. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research.

Collaborations

One of his notable collaborators is Jorge Omar Yanez-Cuna. Their partnership has fostered innovative ideas and has been instrumental in the development of new technologies.

Conclusion

Juan Manuel Iglesias continues to be a driving force in the field of biotechnology, with his patents and collaborations paving the way for future advancements. His work exemplifies the impact of innovation in improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…